Find HDV and Determine Its Status in Turkey
Recruiting
Observational Study
Chronic Hepatitis D Infection
Fibrosis, Liver
Hepatocellular Carcinoma
Cirrhosis, Liver
Transmission Vertical
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20,000 (estimated)
- Sponsor
- Yaşar Bayındır, MD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C vir…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults (Age≥18)
* Being HBsAg positive for at least six months
* Being a citizen of the Republic of Türkiye
Exclusion Criteria:
* There are no exclusion criteria in this study.
Contacts
Mustafa Kemal Çelen, MD
00905336207022
CONTACT